LSC - 2025 - Exploring the antifibrotic potential of the heparan sulfate mimetic OTR4120
Manuela Marega(University of Wuppertal), Savério Bellusci(Universities of Giessen and Marburg Lung Center), Werner Seeger(Justus-Liebig-Universität Gießen), Rainer Pepperkok(European Molecular Biology Laboratory), Chengshui Chen(Wenzhou Medical University), Marek Bartkuhn(Justus-Liebig-Universität Gießen), Arun Lingampally(Universities of Giessen and Marburg Lung Center), Afshin Noori(Cardio-Pulmonary Institute), Cho‐Ming Chao(Helios Universitätsklinikum Wuppertal), Jochen Wilhelm(Justus-Liebig-Universität Gießen), Clemens Ruppert(German Center for Lung Research), Andreas Guenther(Universität Hamburg), Muzamil Majid Khan(German Center for Lung Research), Dulce Papy-García(Université Paris-Est Créteil), Yi Zheng(Ruijin Hospital), Denis Barritault(Délégation Paris 7), Najet Mejdoubi‐Charef(Université Paris-Sud), Joanna Zukowska(European Molecular Biology Laboratory), Ying Dong(Cardio-Pulmonary Institute), Stefano Rivetti(Justus-Liebig-Universität Gießen), Franck Chiappini(Délégation Paris 7), Saïd Charef(Centre National de la Recherche Scientifique), Thomas Muley(German Center for Lung Research), Tara Procida‐Kowalski(Universities of Giessen and Marburg Lung Center), Esmeralda Vásquez‐Pacheco(Justus-Liebig-Universität Gießen), Hauke Winter(German Center for Lung Research), Xuran Chu(Zhanjiang Experimental Station), David Wiegard(Cardio-Pulmonary Institute), Laura Gambs(Universities of Giessen and Marburg Lung Center), Agnès Choppin(Délégation Paris 7)
Cited by 0
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
|Proceedings of the National Academy of Sciences|2013|864
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777